Article
Venous thromboembolism, oral contraceptives and high prothrombin levels.
Journal of thrombosis and haemostasis : JTH - 1 Jan 2003
Legnani C, Cosmi B, Valdrè L, Boggian O, Bernardi F, Coccheri S, Palareti G
Abstract excerpt
The G20210A prothrombin mutation, associated with elevated prothrombin levels, is a risk factor for venous thromboembolism (VTE) and displays a strong interaction with oral contraceptives (OC). No data are available on VTE risk of OC use in women with high prothrombin levels, either associated or not with the mutation. The aim of this study was to evaluate the risk of VTE in OC users with high prothrombin levels,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
